Meeting
2020 Genitourinary Cancers Symposium
Prospective comparison of 68Ga-RM2 PET/CT and 68Ga-PSMA-617 PET/CT for initial staging of prostate cancer.
Authors
Romain Schollhammer Sr.
Nuclear Medicine Department, University Hospital of Bordeaux, Bordeaux, France
Romain Schollhammer Sr., Henri De Clermont-Gallerande Sr., Gregoire Robert Sr., Mokrane Yacoub Sr., Frederic Lamare , Nicolas Balamoutoff , Delphine Vimont , Elif Hindie Sr., Philippe Fernandez Sr., Clément Morgat Sr.
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Imaging
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 21)
Abstract #
21
Poster Bd #
A9
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Pilot study of dual imaging with 89Zr-IAB2M and 68Ga-PSMA-11 PET/CT prior to prostatectomy.
First Author: Muhammad Junaid Niaz
Poster
2024 ASCO Genitourinary Cancers Symposium
Daro-PET: A phase 2 trial of darolutamide as a prostate-specific membrane antigen (PSMA) expression enhancer in patients with localized prostate cancer.
First Author: Jose Mauricio Mota
Poster
2024 ASCO Genitourinary Cancers Symposium
Utility of PSMA PET/CT for imaging ductal carcinoma of the prostate.
First Author: Ahmed M. Mahmoud
Poster
2023 ASCO Annual Meeting
64Cu-SAR-bisPSMA (PROPELLER) positron emission tomography (PET) imaging in patients with confirmed prostate cancer.
First Author: Eva Lengyelova